From: Understanding patient activation and adherence to nebuliser treatment in adults with cystic fibrosis: responses to the UK version of PAM-13 and a think aloud study
Baseline
Age
 Mean (SD)
29.7(11.5)
 Median (IQR)
27(21, 36)
Sex
 Male
36 (56%)
 Female
28 (44%)
FEV 1% Predicted
57.3 (21.3)
49.6 (41.9, 76.7)